# American Red Cross Blood Services, Springfield, MA – FDA Inspections

Source: https://www.keypedia.com/companies/american-red-cross-blood-services/e071de9d-54a8-4cca-add1-8754e02b6952

> Inspection records and compliance data for American Red Cross Blood Services in Springfield, Massachusetts. 8 FDA inspections on record, last inspected June 05, 2026.

---

## Details

- Name: American Red Cross Blood Services
- FEI Number: 1276529
- Address Line 1: 150 Brookdale Dr Ste 100
- City: Springfield
- State: Massachusetts
- Zip Code: 01104
- Country Name: United States
- Address: 150 Brookdale Dr Ste 100, Springfield, Massachusetts 01104, United States
- Country: United States

## Related Documents

- FDA Inspection 1324182 - American Red Cross Blood Services - 2026-06-05 — source: FDA, date: June 5, 2026
- [FDA Inspection 1114962 - American Red Cross Blood Services - 2020-01-07](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/079b036d-5ec6-4598-b77b-323174204b70) — classification: No Action Indicated (NAI), source: FDA, date: January 7, 2020
- FDA Inspection 1062469 - American Red Cross Blood Services - 2018-07-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2018
- FDA Inspection 944773 - American Red Cross Blood Services - 2015-09-17 — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2015
- [FDA Inspection 831874 - American Red Cross Blood Services - 2013-05-03](https://www.keypedia.com/records/fda_inspections/american-red-cross-blood-services/9c32c208-1a53-43b9-af8e-7587611412c8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2013
- FDA Inspection 783488 - American Red Cross Blood Services - 2012-05-04 — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2012
- FDA Inspection 715573 - American Red Cross Blood Services - 2011-03-25 — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2011
- FDA Inspection 571452 - American Red Cross Blood Services - 2009-03-20 — classification: No Action Indicated (NAI), source: FDA, date: March 20, 2009

## Related Companies

- [Daniel J. Pallin, MD, MPH](https://www.keypedia.com/companies/daniel-j-pallin-md-mph/1d3c5ff8-8186-42ea-8bb4-b7613d7aa99b)
- [BlueRock Therapeutics LP](https://www.keypedia.com/companies/bluerock-therapeutics-lp/fe033d83-0781-43b5-bc46-6214da84dad8)
- [Moderna US Inc.](https://www.keypedia.com/companies/moderna-us-inc/f438668d-097e-4fc1-8973-9a122afecdf5)
- [Viacord, LLC](https://www.keypedia.com/companies/viacord-llc/2cadf3b0-a647-484a-be07-b8cd4f530d40)
- [ProMedDx, LLC](https://www.keypedia.com/companies/promeddx-llc/c3405dbe-df76-4238-b5a4-aa6ea63bf27a)
- [Cape Cod Hospital](https://www.keypedia.com/companies/cape-cod-hospital/6aac3d22-7673-4781-886e-9d27c278334e)
- [Vitamin D, Skin and Bone Research Lab](https://www.keypedia.com/companies/vitamin-d-skin-and-bone-research-lab/41e0dc7a-fe26-45ff-97f0-fb9e95b4ad2b)
- [Newton-Wellesley Hospital](https://www.keypedia.com/companies/newton-wellesley-hospital/e6290014-3471-482e-ab8e-61b9285e483b)
- [Metrowest Medical Center-Framingham Campus](https://www.keypedia.com/companies/metrowest-medical-center-framingham-campus/b3c64c15-3389-4443-8cb3-81fc5deba795)
- [Invivo Surgical Systems Inc](https://www.keypedia.com/companies/invivo-surgical-systems-inc/2130309d-ef73-40cb-a26c-02fa13c4a3a8)